ProQR Therapeutics is advancing its Axiomer ADAR-mediated RNA editing pipeline, aiming to file a Clinical Trial Application for its lead program AX-0810, targeting NTCP for cholestatic diseases, by Q2 ...
Lexicon Pharmaceuticals (NASDAQ:LXRX) is one of the fastest-growing penny stocks to buy now. On November 18 at the Jefferies London Healthcare Conference 2025, Lexicon Pharmaceuticals (NASDAQ:LXRX) ...
Hosted on MSN
KRAFTON strengthens new game development pipeline to drive long-term growth in core gaming
Bengaluru (Karnataka) [India], January 16: KRAFTON, Inc. announced its 2026 management strategy and mid-to-long-term growth plans during its company-wide town hall meeting, KRAFTON LIVE TALK (KLT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results